The Company intends to use the net proceeds of the Private Placement to finance its ongoing activities, with a focus on the clinical development of the AB8939 program. This transaction strengthens the ...
Industry Leaders lists, an expansion of the TIME100 Most Influential Companies issue that dives deeper into 20 sectors to ...
NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 (“First ...
Advancing Gold Exploration, Antimony Development, and US Redomiciliation Melbourne, Australia, April 29, 2026 (GLOBE NEWSWIRE ...
"Strong earnings and cash flow results in the quarter achieved our expectations, reflecting the strength of the WM team and the resilience of our business model," said Jim Fish, W ...
GMV up +5.7%, driven by the dynamism of the Marketplace (+13.1%) +10.4% increase in adjusted EBITDA 1 to €110m The Group recorded adjusted EBITDA of €110m in Q1 2026, up +10.4%, despite a context of ...